CVS Health (CVS) Stock Pre-Q2 Earnings: To Buy or Not to Buy?

CVS Health Corporation (CVS) is scheduled to report second-quarter 2024 results on Aug 7, before the opening bell.In the last reported quarter, the company’s adjusted earnings of $1.31 missed the Zacks Consensus Estimate by 22.49%. CVS Health beat estimates in three of the trailing four quarters and missed in one, the average negative surprise being 2.25%.The Zacks Consensus Estimate for revenues is pegged at$ 91.56 billion, suggesting growth of 2.9% year over year. The consensus estimate for second-quarter ...